Previous studies have reported that an increase in circulating adiponectin and leptin-adiponectin ratio may be potential risk factors for breast cancer, colorectal cancer, pancreatic cancer, and endometrial cancer [33,34]. The gene discussed is ADIPOQ; the disease is endometrial cancer.